Temsirolimus suppresses colony formation of head and neck squamous cell carcinoma epithelial cells

Bettina Lück, Anett Reiche, Andreas Boehm, Andreas Dietz, Kristin Herrmann & Gunnar Wichmann
Introduction: The mTOR inhibitor temsirolimus (TEM) is introduced into palliative therapy of advanced head and neck squamous cell carcinoma (HNSCC) after failure of platinum-based chemo- or radiochemotherapy. Purpose: To analyze the effect of TEM and whether TEM combined with cisplatin (Cis) exerts[for full text, please go to the a.m. URL]